Article
Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test.
Prostate cancer and prostatic diseases - 1 Nov 2018
Donovan Michael J, Fernandez Gerardo, Scott Richard, Khan Faisal M, Zeineh Jack, Koll Giovanni, Gladoun Nataliya, Charytonowicz Elizabeth, Tewari Ash, Cordon-Cardo Carlos
Abstract excerpt
BACKGROUND: Postoperative risk assessment remains an important variable in the effective treatment of prostate cancer. There is an unmet clinical need for a test with the potential to enhance the Gleason grading system with novel features that more accurately reflect a personalized prediction of clinical failure. METHODS: A prospectively designed retrospective study utilizing 892 patients, post radical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
